GSK logo

GSK plc (GSK) Operating Profit

Annual Operating Profit:

$5.14B-$4.00B(-43.77%)
December 31, 2024

Summary

  • As of today, GSK annual operating income is $5.14 billion, with the most recent change of -$4.00 billion (-43.77%) on December 31, 2024.
  • During the last 3 years, GSK annual operating profit has fallen by -$1.57 billion (-23.42%).
  • GSK annual operating profit is now -68.69% below its all-time high of $16.41 billion, reached on December 31, 2007.

Performance

GSK Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

Quarterly Operating Profit:

$3.47B+$1.18B(+51.41%)
September 1, 2025

Summary

  • As of today, GSK quarterly operating income is $3.47 billion, with the most recent change of +$1.18 billion (+51.41%) on September 1, 2025.
  • Over the past year, GSK quarterly operating profit has increased by +$2.85 billion (+460.19%).
  • GSK quarterly operating profit is now -22.49% below its all-time high of $4.47 billion, reached on December 31, 2012.

Performance

GSK Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

TTM Operating Profit:

$9.88B+$2.85B(+40.49%)
September 1, 2025

Summary

  • As of today, GSK TTM operating income is $9.88 billion, with the most recent change of +$2.85 billion (+40.49%) on September 1, 2025.
  • Over the past year, GSK TTM operating profit has increased by +$2.63 billion (+36.26%).
  • GSK TTM operating profit is now -34.10% below its all-time high of $14.99 billion, reached on June 30, 2008.

Performance

GSK TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

GSK Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-43.8%+460.2%+36.3%
3Y3 Years-23.4%+40.0%+26.7%
5Y5 Years-36.0%+17.3%+9.0%

GSK Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-43.8%at lowat high+460.2%at high+40.5%
5Y5-Year-43.8%at lowat high+460.2%at high+40.5%
All-TimeAll-Time-68.7%>+9999.0%-22.5%+162.3%-34.1%>+9999.0%

GSK Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
$3.47B(+51.4%)
$9.88B(+40.5%)
Jun 2025
-
$2.29B(-15.0%)
$7.03B(-3.0%)
Mar 2025
-
$2.69B(+88.2%)
$7.25B(+2.5%)
Dec 2024
$5.14B(-43.8%)
$1.43B(+131.3%)
$7.07B(-2.5%)
Sep 2024
-
$618.81M(-75.3%)
$7.25B(-23.4%)
Jun 2024
-
$2.50B(-0.4%)
$9.47B(+4.3%)
Mar 2024
-
$2.51B(+55.8%)
$9.08B(+4.8%)
Dec 2023
$9.14B(+9.7%)
$1.61B(-43.2%)
$8.67B(+5.9%)
Sep 2023
-
$2.84B(+34.5%)
$8.19B(+4.7%)
Jun 2023
-
$2.11B(+0.5%)
$7.82B(+1.7%)
Mar 2023
-
$2.10B(+85.2%)
$7.69B(-0.7%)
Dec 2022
$8.33B(+24.2%)
$1.13B(-54.2%)
$7.74B(-0.7%)
Sep 2022
-
$2.48B(+25.0%)
$7.80B(+3.4%)
Jun 2022
-
$1.98B(-8.0%)
$7.54B(+0.8%)
Mar 2022
-
$2.15B(+81.3%)
$7.49B(+1.1%)
Dec 2021
$6.71B(+14.2%)
$1.19B(-46.6%)
$7.41B(-9.0%)
Sep 2021
-
$2.22B(+15.5%)
$8.14B(-8.3%)
Jun 2021
-
$1.92B(-7.2%)
$8.88B(+2.8%)
Mar 2021
-
$2.07B(+7.9%)
$8.64B(-8.7%)
Dec 2020
$5.88B(-26.9%)
$1.92B(-35.0%)
$9.47B(+4.4%)
Sep 2020
-
$2.96B(+75.5%)
$9.06B(+2.2%)
Jun 2020
-
$1.68B(-41.9%)
$8.87B(-6.3%)
Mar 2020
-
$2.90B(+90.8%)
$9.47B(+5.9%)
Dec 2019
$8.03B(-14.7%)
$1.52B(-44.9%)
$8.94B(-5.6%)
Sep 2019
-
$2.76B(+20.8%)
$9.48B(+2.5%)
Jun 2019
-
$2.29B(-3.9%)
$9.25B(+0.9%)
Mar 2019
-
$2.38B(+15.8%)
$9.16B(+1.4%)
Dec 2018
$9.42B(+20.4%)
$2.05B(-18.8%)
$9.03B(+3.2%)
Sep 2018
-
$2.53B(+15.0%)
$8.75B(+1.5%)
Jun 2018
-
$2.20B(-2.2%)
$8.63B(+10.8%)
Mar 2018
-
$2.25B(+26.6%)
$7.79B(+6.0%)
Dec 2017
$7.83B(-4.2%)
$1.78B(-26.0%)
$7.35B(+1.3%)
Sep 2017
-
$2.40B(+76.6%)
$7.25B(+0.5%)
Jun 2017
-
$1.36B(-24.8%)
$7.22B(-11.4%)
Mar 2017
-
$1.81B(+7.3%)
$8.15B(-0.9%)
Dec 2016
$8.16B(+103.3%)
$1.68B(-28.8%)
$8.22B(+33.7%)
Sep 2016
-
$2.37B(+3.4%)
$6.15B(+7.0%)
Jun 2016
-
$2.29B(+21.8%)
$5.75B(+9.4%)
Mar 2016
-
$1.88B(+587.9%)
$5.26B(+7.2%)
Dec 2015
$4.02B(-43.4%)
-$385.22M(-119.6%)
$4.90B(-37.0%)
Sep 2015
-
$1.97B(+9.5%)
$7.79B(-9.1%)
Jun 2015
-
$1.80B(+17.4%)
$8.57B(-2.3%)
Mar 2015
-
$1.53B(-38.8%)
$8.78B(-6.6%)
Dec 2014
$7.10B(-22.9%)
$2.50B(-9.1%)
$9.39B(+36.2%)
Sep 2014
-
$2.75B(+37.2%)
$6.89B(-1.4%)
Jun 2014
-
$2.00B(-6.7%)
$6.99B(-8.5%)
Mar 2014
-
$2.14B(>+9900.0%)
$7.64B(-5.7%)
Dec 2013
$9.21B(-4.3%)
$0.00(-100.0%)
$8.10B(-35.6%)
Sep 2013
-
$2.84B(+7.2%)
$12.57B(+0.9%)
Jun 2013
-
$2.65B(+1.9%)
$12.46B(-3.3%)
Mar 2013
-
$2.60B(-41.8%)
$12.89B(-2.6%)
Dec 2012
$9.62B(-20.4%)
$4.47B(+63.8%)
$13.22B(+51.1%)
Sep 2012
-
$2.73B(-11.3%)
$8.75B(-5.7%)
Jun 2012
-
$3.08B(+4.7%)
$9.28B(-0.3%)
Mar 2012
-
$2.94B(>+9900.0%)
$9.31B(-0.3%)
Dec 2011
$12.10B(+117.3%)
$0.00(-100.0%)
$9.33B(+33.9%)
Sep 2011
-
$3.26B(+4.8%)
$6.97B(+5.3%)
Jun 2011
-
$3.11B(+4.7%)
$6.62B(+90.9%)
Mar 2011
-
$2.97B(+225.8%)
$3.47B(+1.1%)
Dec 2010
$5.57B(-57.8%)
-$2.36B(-181.3%)
$3.43B(-63.0%)
Sep 2010
-
$2.91B(+6586.0%)
$9.26B(-4.1%)
Jun 2010
-
-$44.80M(-101.5%)
$9.66B(-23.1%)
Mar 2010
-
$2.93B(-15.6%)
$12.57B(+1.4%)
Dec 2009
$13.20B(-0.1%)
$3.47B(+5.1%)
$12.39B(+3.8%)
Sep 2009
-
$3.30B(+15.5%)
$11.94B(+38.3%)
Jun 2009
-
$2.86B(+3.9%)
$8.63B(-9.7%)
Mar 2009
-
$2.76B(-8.7%)
$9.57B(-9.4%)
Dec 2008
$13.21B(-19.5%)
$3.02B(>+9900.0%)
$10.56B(-6.0%)
Sep 2008
-
$0.00(-100.0%)
$11.24B(-25.0%)
Jun 2008
-
$3.79B(+1.1%)
$14.99B(+1.0%)
Mar 2008
-
$3.75B(+1.6%)
$14.84B(-0.5%)
Dec 2007
$16.41B(+14.0%)
$3.69B(-1.6%)
$14.92B(+4.4%)
Sep 2007
-
$3.75B(+3.2%)
$14.29B(+0.9%)
Jun 2007
-
$3.64B(-4.9%)
$14.15B(+1.6%)
Mar 2007
-
$3.83B(+25.0%)
$13.93B(+1.0%)
Dec 2006
$14.39B(+2074.0%)
$3.06B(-15.4%)
$13.78B(+2.0%)
Sep 2006
-
$3.62B(+6.2%)
$13.52B(+6.0%)
Jun 2006
-
$3.41B(-7.4%)
$12.75B(+2.0%)
Mar 2006
-
$3.69B(+31.7%)
$12.51B(+5.6%)
Dec 2005
$661.92M
$2.80B(-2.0%)
$11.85B(+5.6%)
Sep 2005
-
$2.86B(-9.9%)
$11.22B(+1.7%)
DateAnnualQuarterlyTTM
Jun 2005
-
$3.17B(+4.7%)
$11.03B(+5.3%)
Mar 2005
-
$3.03B(+39.7%)
$10.48B(+2.8%)
Dec 2004
$10.54B(+1.0%)
$2.17B(-18.8%)
$10.19B(-0.6%)
Sep 2004
-
$2.67B(+2.0%)
$10.25B(-2.5%)
Jun 2004
-
$2.61B(-4.7%)
$10.51B(-3.9%)
Mar 2004
-
$2.74B(+23.4%)
$10.93B(-1.1%)
Dec 2003
$10.44B(+3.8%)
$2.22B(-24.1%)
$11.05B(-4.0%)
Sep 2003
-
$2.93B(-3.5%)
$11.51B(+6.9%)
Jun 2003
-
$3.04B(+6.0%)
$10.76B(+6.3%)
Mar 2003
-
$2.86B(+6.9%)
$10.13B(+8.7%)
Dec 2002
$10.06B(+14.4%)
$2.68B(+22.7%)
$9.32B(+8.9%)
Sep 2002
-
$2.18B(-8.9%)
$8.56B(+2.8%)
Jun 2002
-
$2.40B(+16.8%)
$8.32B(+2.0%)
Mar 2002
-
$2.05B(+6.9%)
$8.16B(+0.3%)
Dec 2001
$8.79B(+69.5%)
$1.92B(-1.5%)
$8.14B(+778.1%)
Sep 2001
-
$1.95B(-12.8%)
$926.77M(-61.2%)
Jun 2001
-
$2.24B(+10.1%)
$2.39B(-38.8%)
Mar 2001
-
$2.03B(+138.4%)
$3.90B(-30.3%)
Dec 2000
$5.19B(+14.5%)
-$5.29B(-255.1%)
$5.60B(+5.1%)
Sep 2000
-
$3.41B(-9.0%)
$5.32B(-4.2%)
Jun 2000
-
$3.75B(+0.6%)
$5.56B(+91.5%)
Mar 2000
-
$3.73B(+167.0%)
$2.90B(+17.9%)
Dec 1999
$4.53B(+3.0%)
-$5.56B(-252.6%)
$2.46B(-3.5%)
Sep 1999
-
$3.65B(+233.8%)
$2.55B(+10.6%)
Jun 1999
-
$1.09B(-66.8%)
$2.31B(+3.7%)
Mar 1999
-
$3.29B(+160.1%)
$2.23B(+5.1%)
Dec 1998
$4.40B(-7.3%)
-$5.47B(-260.9%)
$2.12B(-4.0%)
Sep 1998
-
$3.40B(+236.4%)
$2.21B(+7.1%)
Jun 1998
-
$1.01B(-68.2%)
$2.06B(-52.5%)
Mar 1998
-
$3.18B(+159.1%)
$4.34B(-3.5%)
Dec 1997
$4.75B(-2.8%)
-$5.38B(-265.5%)
$4.50B(-34.3%)
Sep 1997
-
$3.25B(-1.1%)
$6.85B(-8.2%)
Jun 1997
-
$3.29B(-1.4%)
$7.47B(+1.4%)
Mar 1997
-
$3.34B(+210.1%)
$7.36B(+1.1%)
Dec 1996
$4.88B(-13.3%)
-$3.03B(-178.4%)
$7.28B(-29.4%)
Sep 1996
-
$3.87B(+21.3%)
$10.31B(+14.5%)
Jun 1996
-
$3.19B(-2.1%)
$9.01B(+1745.6%)
Mar 1996
-
$3.26B(+27.0%)
$488.17M(-79.4%)
Dec 1995
$5.63B(+107.7%)
-
-
Sep 1995
-
$2.56B(+148.1%)
$2.37B(+1.4%)
Jun 1995
-
-$5.33B(-310.9%)
$2.34B(-39.5%)
Mar 1995
-
$2.53B(-3.3%)
$3.87B(+7.4%)
Dec 1994
-
$2.61B(+3.3%)
$3.60B(+15.9%)
Sep 1994
-
$2.53B(+166.5%)
$3.11B(+16.4%)
Jun 1994
$2.71B(+9.8%)
-$3.80B(-268.3%)
$2.67B(-8.5%)
Mar 1994
-
$2.26B(+6.6%)
$2.92B(+1.1%)
Dec 1993
-
$2.12B(+1.3%)
$2.89B(+12.1%)
Sep 1993
-
$2.09B(+158.9%)
$2.57B(+9.9%)
Jun 1993
$2.47B(+8.6%)
-$3.56B(-259.6%)
$2.34B(+8.2%)
Mar 1993
-
$2.23B(+23.3%)
$2.16B(+12.9%)
Dec 1992
-
$1.81B(-2.9%)
$1.92B(-2.1%)
Sep 1992
-
$1.86B(+149.8%)
$1.96B(-0.6%)
Jun 1992
$2.27B(>+9900.0%)
-$3.74B(-288.5%)
$1.97B(+20.2%)
Mar 1992
-
$1.98B(+7.2%)
$1.64B(+40.1%)
Dec 1991
-
$1.85B(-1.3%)
$1.17B(+64.4%)
Sep 1991
-
$1.87B(+146.1%)
$711.22M(+242.0%)
Jun 1991
$0.00(0.0%)
-$4.07B(-368.8%)
$207.96M(-58.2%)
Mar 1991
-
$1.51B(+8.7%)
$497.92M(+75.9%)
Dec 1990
-
$1.39B(+1.5%)
$283.05M(+235.0%)
Sep 1990
-
$1.37B(+136.3%)
$84.50M(+185.9%)
Jun 1990
$0.00(0.0%)
-$3.78B(-390.9%)
-$98.40M(-112.7%)
Mar 1990
-
$1.30B(+8.8%)
$777.73M(+56.2%)
Dec 1989
-
$1.19B(+0.5%)
$497.95M(+59.5%)
Sep 1989
-
$1.19B(+140.9%)
$312.15M(+117.9%)
Jun 1989
$0.00(0.0%)
-$2.90B(-384.8%)
$143.23M(-67.2%)
Mar 1989
-
$1.02B(+1.1%)
$436.08M(+54.9%)
Dec 1988
-
$1.01B(-1.1%)
$281.52M(+216.2%)
Sep 1988
-
$1.02B(+139.1%)
$89.02M(+232.6%)
Jun 1988
$0.00(0.0%)
-$2.61B(-401.9%)
-$67.13M(-115.3%)
Mar 1988
-
$863.72M(+6.1%)
$437.86M(+51.8%)
Dec 1987
-
$814.42M(-5.5%)
$288.45M(+170.5%)
Sep 1987
-
$862.23M(+141.0%)
$106.62M(+228.7%)
Jun 1987
$0.00(0.0%)
-$2.10B(-394.3%)
-$82.85M(-126.0%)
Mar 1987
-
$714.30M(+12.9%)
$318.48M(+117.8%)
Dec 1986
-
$632.59M(-6.0%)
$146.21M(+135.6%)
Sep 1986
-
$672.76M(+139.5%)
$62.07M(+188.4%)
Jun 1986
$0.00(0.0%)
-$1.70B(-413.8%)
-$70.25M(-104.3%)
Mar 1986
-
$542.04M(-1.2%)
$1.63B(+49.8%)
Dec 1985
-
$548.45M(+1.5%)
$1.09B(+101.5%)
Sep 1985
-
$540.44M
$540.44M
Jun 1985
$0.00(0.0%)
-
-
Jun 1984
$0.00
-
-

FAQ

  • What is GSK plc annual operating income?
  • What is the all-time high annual operating profit for GSK plc?
  • What is GSK plc annual operating profit year-on-year change?
  • What is GSK plc quarterly operating income?
  • What is the all-time high quarterly operating profit for GSK plc?
  • What is GSK plc quarterly operating profit year-on-year change?
  • What is GSK plc TTM operating income?
  • What is the all-time high TTM operating profit for GSK plc?
  • What is GSK plc TTM operating profit year-on-year change?

What is GSK plc annual operating income?

The current annual operating profit of GSK is $5.14B

What is the all-time high annual operating profit for GSK plc?

GSK plc all-time high annual operating income is $16.41B

What is GSK plc annual operating profit year-on-year change?

Over the past year, GSK annual operating income has changed by -$4.00B (-43.77%)

What is GSK plc quarterly operating income?

The current quarterly operating profit of GSK is $3.47B

What is the all-time high quarterly operating profit for GSK plc?

GSK plc all-time high quarterly operating income is $4.47B

What is GSK plc quarterly operating profit year-on-year change?

Over the past year, GSK quarterly operating income has changed by +$2.85B (+460.19%)

What is GSK plc TTM operating income?

The current TTM operating profit of GSK is $9.88B

What is the all-time high TTM operating profit for GSK plc?

GSK plc all-time high TTM operating income is $14.99B

What is GSK plc TTM operating profit year-on-year change?

Over the past year, GSK TTM operating income has changed by +$2.63B (+36.26%)
On this page